Power to the Patients

Brandon Li
  • 0.0 (0)
  • LIFE SCIENCES
  • UPDATED WEEKLY
Power to the Patients

Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com

  1. 19/12/2024

    Bringing the Consumer Experience to Clinical Research

    In this episode of Power to the Patients, Srinivas Pai sits down with Katie Baca-Motes, Co-Founder at Scripps Research Digital Trial Center, to discuss how clinical research can learn from consumer industries to create better patient experiences. They explore advancements in digital clinical trials, behavioral science, patient-centric design, and the importance of diversity and equity in research. Katie also shares her unique insights from her time at Disney and her vision for transforming clinical research into a more inclusive and engaging space.   Key Takeaways: Patient-Centric Design: Clinical research often prioritizes researcher convenience over patient experience. Katie advocates designing trials with patients as true partners, incorporating motivations beyond financial incentives, such as learning, community, and altruism. Diversity and Equity: Building diversity into clinical trials from the planning stage is essential. Katie highlights the importance of including representative voices early on and addressing barriers like geographical and digital divides. Digital as a Bridge: Digital tools are not just for convenience; they can bridge gaps in access to clinical trials for underserved populations, especially in rural areas. Learning from Consumer Industries: Drawing from her experience at Disney, Katie stresses the importance of creating a seamless and engaging experience for participants. From onboarding to returning results, every touchpoint should enhance patient trust and retention. Reducing Barriers Through Behavioural Science: Katie highlights how applying behavioral science principles, like A/B testing and understanding participant motivations, can address key drop-off points in clinical trials. This approach ensures that trials are not just functional but also participant-friendly.

    24 min

  2. 12/12/2024

    A New Frontier of Psychedelic Therapies

    In this episode, Brandon Li sits down with Manish Agrawal, Co-Founder and CEO of Sunstone Therapies, to discuss the transformative role of psychedelics in cancer care and mental health.  Manish shares his journey from oncology to leading groundbreaking research in psychedelic-assisted therapy, emphasizing its profound potential to address emotional and psychological needs that traditional medicine often overlooks. Key topics include: - Manish’s career pivot: Why seeing unmet emotional needs in oncology patients inspired Manish to transition into psychedelic research. - Complexity of psychedelic therapy: How combining psychedelics with psychological support creates a unique treatment model. - Challenges in research: How subjective patient experiences challenge traditional clinical research methods. - Patient stories: Profound moments of transformation, from facing mortality to finding peace and acceptance. - The future of psychedelics in healthcare: How tailored approaches can integrate psychedelics into mainstream care while addressing stigma and operational challenges. Tune in to hear how Manish Agrawal and Sunstone Therapies are navigating this exciting frontier.

    36 min

  3. 06/12/2024

    A Pragmatic Approach to Psychedelic Drug Development

    In this episode, Brandon Li sits down with Srinivas Rao, Co-CEO of atai Life Sciences, for a deep dive into the pragmatic strategies shaping the future of psychedelic therapies. Srini shares how his background in engineering and neuropharmacology has informed a streamlined, patient-centric approach to drug development. Key topics include: The evolution of atai Life Sciences, from a fund to a biotech company. Innovative drug delivery approaches, like DMT oral thin films, and why simplicity and scalability matter. Balancing diverse compounds and therapeutic areas with a focused portfolio strategy. Advancing research in areas like social anxiety disorder and cognitive impairment in schizophrenia. Tackling clinical trial challenges, including the placebo effect and trial design complexities. Tune in to hear how a pragmatic lens is redefining what’s possible in neuropsychiatric drug development.

    50 min

  4. 31/10/2024

    Building a High Recruiting Site in Alzheimer's

    In this episode, Jessica Branning, President of JBran Consulting and former CEO of ClinCloud, shares her  work in creating accessible and patient-focused clinical research sites in the neuropsych space. Jessica’s journey takes us from her early days as a clinical research coordinator to founding ClinCloud, a fully remote-capable site specializing in Alzheimer’s and dementia trials. Tune in as we dive into: How technology like EMR integrations and virtual pre-screening is transforming patient recruitment. The importance of building an ecosystem of support for Alzheimer's patients and their caregivers. Key challenges and learnings in making clinical trials more accessible, including community engagement and education. Whether you’re in clinical research, patient care, or interested in the latest in neuropsychiatry trials, Jessica’s story of building a compassionate, tech-forward site is sure to inspire.

    46 min

  5. 09/10/2024

    Why Beckley Psytech is Developing the Next Generation of Psychedelics

    In this episode, Brandon Li sits down with Cosmo Feilding-Mellen, CEO of Beckley Psytech, to explore the groundbreaking work Beckley is doing in the world of psychedelics. Cosmo shares his journey growing up in a family immersed in psychedelic research, co-founding Beckley Psytech, and pushing the boundaries of mental health treatment with next-generation compounds like 5-MeO-DMT. Tune in to discover why Beckley Psytech is focusing on shorter, scalable psychedelic treatments for conditions like treatment-resistant depression and substance use disorders. Cosmo explains how their innovative approach aims to make these therapies more accessible while maintaining high ethical standards, balancing cutting-edge science with compassionate care. Learn about the future of psychedelics as pharmaceutical medicines, and what it takes to develop new treatments in this rapidly evolving field.

    39 min

  6. 03/10/2024

    The Mental Health Epidemic in Rural America

    In this episode, we sit down with Jeff Winton, Founder and Chairman of Rural Minds, a nonprofit dedicated to advocating for mental health services in rural America. Jeff shares his deeply personal story of how a family tragedy inspired the creation of Rural Minds and sheds light on the mental health crisis in rural communities, where stigma and lack of access to care create unique challenges. He talks about his career in the biopharmaceutical industry and how it shaped his approach to advocacy. From the isolation of rural life to the growing pressure on fragile healthcare infrastructures, Jeff emphasizes the urgent need for mental health equity and offers insights into how we can better support underserved populations. Listen in to learn more about how Rural Minds is making an impact and why storytelling is central to breaking the silence surrounding mental illness in rural America.

    41 min

  7. 26/09/2024

    Going All In on Psilocybin for Depression

    In this episode, we sit down with Doug Drysdale, CEO of Cybin, to discuss the growing interest in psilocybin as a potential treatment for depression and other mental health conditions. Doug talks candidly about his initial skepticism and how the data convinced him to dive into the world of psychedelic medicine. With decades of experience in drug development, Doug shares why he believes psilocybin represents a new approach to mental health care—one that could provide alternatives to traditional treatments like SSRIs. We explore Cybin's ongoing research, the results from their recent phase two studies, and what’s next as they prepare for phase three trials. Doug also discusses the challenges of working in a field that still faces regulatory hurdles and public stigma, and how his company is navigating these complexities. This conversation is a thoughtful look at the potential of psychedelics in medicine—what's real, what's still uncertain, and what the future might hold for patients seeking new options for managing depression and anxiety. If you're curious about the science behind psilocybin or want to understand where the field of psychedelic medicine is headed, this episode offers an honest and grounded perspective from a leader in the space.

    44 min

  8. 19/09/2024

    Psychedelics and the Future of Anxiety Relief

    In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety. He shares his personal journey through psychiatry and addiction medicine, discussing the limitations of traditional treatments and the hope that psychedelics might bring. We dive into MindMed’s research on how LSD could impact generalized anxiety disorder (GAD), with Dr. Karlin explaining how it works and the importance of therapy alongside these treatments. This insightful conversation explores how MindMed is leading the way in developing new solutions for mental health, which could change the way we treat anxiety.

    39 min
See All (18)

About

Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com

Information

  • Creator
    Brandon Li
  • Years Active
    2023 - 2024
  • Episodes
    18
  • Rating
    Clean
  • Copyright
    © 2023
  • Show Website
    Power to the Patients

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada